Bacterial Infections
253
22
27
172
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Published Results
37 trials with published results (15%)
Research Maturity
172 completed trials (68% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.3%
11 terminated out of 253 trials
94.0%
+7.5% vs benchmark
19%
49 trials in Phase 3/4
22%
37 of 172 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 172 completed trials
Clinical Trials (253)
A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity
Dose-finding, Pharmacokinetics, and Safety of VABOMERE in Pediatric Subjects With Bacterial Infections
Clinical Efficacy and Population Pharmacokinetics of β-lactams in Cirrhotic Patients
Large Algorithm Setting and Validation Study
Study of the Involvement of IL-17 / IL-22 Pathway in Bacterial Exacerbations of COPD
Emergency PWAS in Respiratory Infectious Disease
Prospective Clinical Registry of Acute Treatment and Long-term Assessment of Children Meningitis
A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women
Prospective Clinical Study, Using a Medical Device (RepHegyn) as an Adjuvant in the Treatment of Fungal (Candidiasis) and Bacterial Infections
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
Viromes in Infants Presenting With a Septic Syndrome
Study to Evaluate the PK of IV and PO Omadacycline in Children and Adolescents With Suspected or Confirmed Bacterial Infections
A Study to Evaluate the Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine (PCV13i) in Healthy Infants Aged 2 Months (Minimum 6 Weeks)
Healthrelated Quality of Life and Experiences of a Heart Rehabilitation Programme After Care for Infective Endocarditis.
TDM-optimized Teicoplanin Dosing Versus Standard of Care
[18F]Fluoropropyl-Trimethoprim ([18F]F-TMP) PET/CT Imaging to Evaluate Biodistribution and Kinetics in Human Subjects
11C-Trimethoprim PET/CT Imaging to Evaluate Biodistribution and Kinetics in Human Subjects
P1, DDI & MAD PK and Safety Study of Xeruborbactam Oral Prodrug in Combo With Ceftibuten in Healthy Participants
Biodistribution and Pathophysiology Study of 11C-para-aminobenzoic Acid
Diagnostic Evaluation Study of the BactInsight Blood Culture System in West-Africa